MHP
VIVE

Manatuck Hill Partners’s VIVEVE MED INC VIVE Stock Holding History

Manatuck Hill Partners’s Portfolio VIVE Stock Details VIVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-400
Closed -$2.87M – 103
2017
Q2 		$2.87M Buy
400
+225
+129% +$1.68M 1.44% 23
2017
Q1 		$1.11M Buy
+175
New +$851K 0.48% 47

Other funds holding VIVE

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IG
ING Group Amsterdam, Netherlands $16.4B AUM 34.6% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return

Manatuck Hill Partners's VIVE Position: Q3 2017 in Review

Manatuck Hill Partners sold out of VIVEVE MED INC (VIVE) in Q3 2017, closing a stake of 400 shares — an estimated $2.87M sold.

Manatuck Hill Partners first reported a position in VIVE in Q1 2017 and held it in 2 quarters. The position peaked at $2.87M in Q2 2017. 48 funds tracked by Wall St. Rank hold VIVE as of Q3 2017.

  • Manatuck Hill Partners reported no remaining VIVEVE MED INC position as of Q3 2017 after selling out during the quarter.
  • Manatuck Hill Partners sold 400 VIVEVE MED INC shares in Q3 2017, an estimated $2.87M.
  • Manatuck Hill Partners first reported a position in VIVEVE MED INC in Q1 2017 and held it in 2 quarters.
  • Manatuck Hill Partners's VIVEVE MED INC position peaked at $2.87M in Q2 2017.
  • 48 funds tracked by Wall St. Rank held VIVEVE MED INC as of Q3 2017.

Based on Manatuck Hill Partners's 13F filing for Q3 2017, filed 14 Nov 2017.